| Host: | Rabbit |
| Applications: | WB/IHC/IF/ELISA |
| Reactivity: | Human/Mouse |
| Note: | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description : | Rabbit polyclonal antibody anti-Serine/arginine-rich splicing factor 4 (111-160 aa) is suitable for use in Western Blot, Immunohistochemistry, Immunofluorescence and ELISA research applications. |
| Clonality : | Polyclonal |
| Conjugation: | Unconjugated |
| Isotype: | IgG |
| Formulation: | Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide. |
| Purification: | The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. |
| Concentration: | 1 mg/mL |
| Dilution Range: | WB 1:500-1:2000IHC 1:100-1:300ELISA 1:20000IF 1:50-200 |
| Storage Instruction: | Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
| Gene Symbol: | SRSF4 |
| Gene ID: | 6429 |
| Uniprot ID: | SRSF4_HUMAN |
| Immunogen Region: | 111-160 aa |
| Specificity: | SRp75 Polyclonal Antibody detects endogenous levels of SRp75 protein. |
| Immunogen: | The antiserum was produced against synthesized peptide derived from the human SFRS4 at the amino acid range 111-160 |
| Function | Plays a role in alternative splice site selection during pre-mRNA splicing. Represses the splicing of MAPT/Tau exon 10. |
| Protein Name | Serine/Arginine-Rich Splicing Factor 4Pre-Mrna-Splicing Factor Srp75Srp001lbSplicing Factor - Arginine/Serine-Rich 4 |
| Database Links | Reactome: R-HSA-159236Reactome: R-HSA-72163Reactome: R-HSA-72187Reactome: R-HSA-72203Reactome: R-HSA-73856 |
| Cellular Localisation | Nucleus Speckle |
| Alternative Antibody Names | Anti-Serine/Arginine-Rich Splicing Factor 4 antibodyAnti-Pre-Mrna-Splicing Factor Srp75 antibodyAnti-Srp001lb antibodyAnti-Splicing Factor - Arginine/Serine-Rich 4 antibodyAnti-SRSF4 antibodyAnti-SFRS4 antibodyAnti-SRP75 antibody |
Information sourced from Uniprot.org
